Gould Capital’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $638 | Hold |
100
| – | – | ﹤0.01% | 206 |
|
|
2025
Q1 | $486 | Hold |
100
| – | – | ﹤0.01% | 205 |
|
|
2024
Q4 | $956 | Hold |
100
| – | – | ﹤0.01% | 197 |
|
|
2024
Q3 | $835 | Hold |
100
| – | – | ﹤0.01% | 202 |
|
|
2024
Q2 | $682 | Hold |
100
| – | – | ﹤0.01% | 206 |
|
|
2024
Q1 | $253 | Hold |
100
| – | – | ﹤0.01% | 189 |
|
|
2023
Q4 | $240 | Hold |
100
| – | – | ﹤0.01% | 192 |
|
|
2023
Q3 | $316 | Hold |
100
| – | – | ﹤0.01% | 192 |
|
|
2023
Q2 | $735 | Buy |
+100
| New | +$735 | ﹤0.01% | 186 |
|